DSM-5 Substance Use Disorders among College-Age Young Adults in the United States: Prevalence, Remission and Treatment

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Availability:
      Taylor & Francis. Available from: Taylor & Francis, Ltd. 530 Walnut Street Suite 850, Philadelphia, PA 19106. Tel: 800-354-1420; Tel: 215-625-8900; Fax: 215-207-0050; Web site: http://www.tandf.co.uk/journals
    • Peer Reviewed:
      Y
    • Source:
      8
    • Sponsoring Agency:
      National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH)
      National Cancer Institute (NCI) (NIH)
      National Institute on Drug Abuse (NIDA) (DHHS/PHS)
    • Contract Number:
      R01AA025684
      T32AA007477
      R01CA203809
      R01CA212517
      R01DA031160
      R01DA036541
      R01DA043691
      R01DA043696
    • Education Level:
      Higher Education
      Postsecondary Education
    • Subject Terms:
    • Accession Number:
      10.1080/07448481.2019.1590368
    • ISSN:
      0744-8481
    • Abstract:
      Objective: To determine the prevalence, remission, and treatment associated with DSM-5 substance use disorders (SUDs) among young adults based on college attendance. Participants: The population-based sample included 2,057 young adults aged 19-23 in college/school and 1,213 not currently attending college/school who participated from April 2012 through June 2013. Methods: Face-to-face interviews were conducted as part of a cross-sectional national survey. Results: The prevalence of any past-year DSM-5 SUD was 39.6% among young adults in college and 44.5% among those not attending college. Past-year tobacco use disorder and multiple DSM-5 SUDs were more prevalent among those not attending college. Among those with prior-to-past-year SUDs, abstinent remission was low among college (1.0%) and noncollege (1.9%) young adults. Conclusions: Approximately two in five U.S. college students had at least one past-year DSM-5 SUD. Sustained abstinent remission from SUDs is extremely rare (1-2%) and the majority of those with SUDs do not receive treatment.
    • Abstract:
      As Provided
    • Notes:
      https://www.niaaa.nih.gov/research/nesarc-iii
    • Publication Date:
      2020
    • Accession Number:
      EJ1268865